VisionPoint Advisory Group »

Amneal Pharmaceuticals shares owned by VisionPoint Advisory Group

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by VisionPoint Advisory Group from 13F filings

Historical chart of VisionPoint Advisory Group investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by VisionPoint Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by VisionPoint Advisory Group

Quarter filed Position value Share count Share price at filing
2026-09-30 $217k 11k 20.14

More positions owned by VisionPoint Advisory Group

Spdr Series Trust St Str P500etf (SPYM)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Univrsl Usd (IUSB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr Series Trust ST STR PR SP1500 (SPTM)
Ishares Tr S&p 500 Grwt Etf (IVW)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Spdr Series Trust St Str Blo 1 Etf (BIL)
Deere & Company (DE)
Spdr Series Trust St Str Sp Div (SDY)

View all positions for VisionPoint Advisory Group

Top funds holding Amneal Pharmaceuticals

BlackRock
Tpg Gp A
Vanguard Portfolio Management
Rubric Capital Management
Vanguard Capital Management
Dimensional Fund Advisors
Geode Capital Management
Neuberger Berman Group
Invesco
Nuveen
Allspring Global Investments Holdings
Goldman Sachs Group
Nantahala Capital Management
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Amneal Pharmaceuticals